Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nikolay N. Kalitin"'
Autor:
Nikolay N. Kalitin, Lidia V. Ektova, Natalia S. Kostritsa, Anastasia S. Sivirinova, Alexander V. Kostarev, Galina B. Smirnova, Yulia A. Borisova, Irina S. Golubeva, Elisaveta V. Ermolaeva, Maria A. Vergun, Maria A. Babaeva, Anna A. Lushnikova, Aida F. Karamysheva
Publikováno v:
Chemico-Biological Interactions. 364:110056
In recent decades, indolocarbazole glycosides containing sugar moieties have attracted attention due to their diverse anti-tumor activities. In the present study, a series of new indolo [2,3-a]pyrrolo [3,4-c]carbazole derivatives were synthesized for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6c49ad8a35d6e731b7e4aef74eaaf8
https://doi.org/10.1016/j.cbi.2022.110056
https://doi.org/10.1016/j.cbi.2022.110056
Publikováno v:
Cell Biology International. 40:456-464
The regulation of vascular endothelial growth factors C (VEGF-C) and D (VEGF-D), and their receptor VEGFR3 gene and protein expression by all-trans-retinoic acid (atRA) in A549 lung cancer cells, was investigated. We showed that atRA treatment increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::742f52661d0f10639b690548807aa2fe
https://doi.org/10.1002/cbin.10587
https://doi.org/10.1002/cbin.10587
Publikováno v:
Cell biology international. 40(4)
The regulation of vascular endothelial growth factors C (VEGF-C) and D (VEGF-D), and their receptor VEGFR3 gene and protein expression by all-trans-retinoic acid (atRA) in A549 lung cancer cells, was investigated. We showed that atRA treatment increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd4850839913060de5f2de327cc0a407
https://pubmed.ncbi.nlm.nih.gov/26818829
https://pubmed.ncbi.nlm.nih.gov/26818829
Autor:
Kalitin N; Laboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation; f.oskolov@mail.ru., Dudina G; Department of Oncohematology, A.S. Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation., Kostritsa N; Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Moscow, Russian Federation., Sivirinova A; Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Moscow, Russian Federation., Vaiman A; Laboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation., Karamysheva A; Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Moscow, Russian Federation.
Publikováno v:
In vivo (Athens, Greece) [In Vivo] 2024 Mar-Apr; Vol. 38 (2), pp. 657-664.
Autor:
Kalitin N; Laboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia., Dudina G; Department of Oncohematology, A.S. Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia., Kostritsa N; Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, 119234 Moscow, Russia., Sivirinova A; Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, 119234 Moscow, Russia., Karamysheva A; Laboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Publikováno v:
Oncology letters [Oncol Lett] 2023 Jan 26; Vol. 25 (3), pp. 95. Date of Electronic Publication: 2023 Jan 26 (Print Publication: 2023).